Home » Topics » BioWorld Science

BioWorld Science
RSS

Anti-ANXA1 antibody MDX-124 shows promise in preclinical models of pancreatic cancer

Jan. 24, 2022

HS6ST2 predicts survival in PDAC

Jan. 24, 2022

IM-1761065, a novel biguanide with promising activity in models of glioblastoma

Jan. 24, 2022

Oasmia advances its next-generation XR-18 drug delivery technology

Jan. 24, 2022

Engineered virus-like particles for in vivo delivery of gene editing proteins

Jan. 24, 2022

New approach integrates CAR-T cell immunotherapy with local activation of small-molecule prodrugs

Jan. 24, 2022

Inventisbio Shanghai discloses GTPase KRAS mutant inhibitors

Jan. 24, 2022

Shanghai Institute of Materia Medica identifies new S1PR1 agonists

Jan. 24, 2022

Immunophage Biomedical presents new CCR8 antagonists

Jan. 24, 2022

Sichuan Haisco Pharmaceutical discloses new JAK inhibitors

Jan. 24, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...